Fundraise / allotmentFiled on BSE ·
Embassy Developments Limited allots 3.25 crore convertible warrants on preferential basis
What the filing says
- On October 12, 2026, Embassy Developments Limited allotted 3,25,18,900 unlisted convertible warrants at ₹111.51 each
- Warrants were allotted to Embassy Property Developments Private Limited, a promoter group entity, for ₹90.65 crore (25% subscription amount)
- Warrants convertible into equity shares within 6 months, with lock-in as per SEBI ICDR Regulations; shareholder and stock exchange approvals obtained
Original filing
Announcement under Regulation 30 (LODR)-Allotment
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Revenue growth 40%+Margin up 2%+
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Embassy Developments Ltd
- Fundraise / allotmentEmbassy Developments Limited credit rating upgraded to IVR A/Stable on Oct 9, 2026
- Board / shareholder meeting outcomeEmbassy Developments Limited holds 20th AGM approving financials and appointments
Other fundraise / allotment filings this fortnight
- Fundraise / allotmentMold-Tek TechnolMold-Tek Technologies approves allotment of bonus shares in 1:1 ratio
- Fundraise / allotmentMold-Tek Packaging LtdMold-Tek Packaging Limited approves allotment of bonus equity shares 1:1
- Fundraise / allotmentJubilant Pharmova LtdJubilant Pharmova approves issuance of up to ₹800 crore NCDs on private placement
- Fundraise / allotmentJubilant Pharmova LtdJubilant Pharmova Limited approves issuance of up to ₹800 crore NCDs on private placement
- Fundraise / allotmentJTL Defence LtdJTL Defence Limited schedules Board Meeting on October 14, 2026 for Rights Issue approval
- Fundraise / allotmentPTC Industries LtdPTC Industries Limited allots 8,54,700 equity shares via qualified institutional placement
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.